| 中文名称: | (1S,2S,3S,5S)-3-(苄氧基)-5-(6-(苄氧基)-2-(((4-甲氧基苯基)二苯甲基)氨基)-9H-嘌呤-9-基)-2-((苄氧基)甲基)环戊醇 |
| 中文别名: | 恩替卡韦中间体N5;(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇;(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9;(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基];N,N'-双(1-乙基-3-甲基戊基)-1,4-苯二胺;N,N-双(1-乙基-3-甲基戊基)-1,4-苯二胺;恩替卡韦 中间体-5;恩替卡韦-5;恩替卡韦杂质1;恩替卡韦中间体;恩替卡韦中间体5;恩替卡韦中间体N5,(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇;恩替卡韦中间体五;(2R,3S,5S)-3-苄氧基-5-(2-(((4-甲氧基苯基)二苯基甲基)氨基)-6-苄氧基-9H-嘌呤-9-基)-2-苄氧基甲基环戊醇;(1S,2S,3S,5S)-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-(苯基甲氧基)-9H-嘌呤-9-基]-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇;恩替卡韦中间体 N5 |
| smiles: | O(C([H])([H])C1C([H])=C([H])C([H])=C([H])C=1[H])[C@@]1([H])C([H])([H])[C@@]([H])(C([H])([C@@]1([H])C([H])([H])OC([H])([H])C1C([H])=C([H])C([H])=C([H])C=1[H])O[H])N1C([H])=NC2C(=NC(N([H])C(C3C([H])=C([H])C([H])=C([H])C=3[H])(C3C([H])=C([H])C([H])=C([H])C=3[H])C3C([H])=C([H])C(=C([H])C=3[H])OC([H])([H])[H])=NC1=2)OC([H])([H])C1C([H])=C([H])C([H])=C([H])C=1[H] |
| 英文名称: | (1S,2S,3S,5S)-3-(Benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanol |
| 英文别名: | (1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanol;(2R,3S,5S)-3-(Benzyloxy)-5-(6-benzyloxy)-2-(4-methyoxyphenyl)diphenylmethylamino)-9H-purin-9-yl)-2-benzyloxymethyl)cyclopentanol;(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol;Entecavir intermediate N5;(1S,2S,3S,5S)-3-(Benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl amino)-9H-purin-9-yl)-2-((benzyloxy)me...;(1S,2S,3S,5S)-3-(Benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl amino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanol;(2R,3S,5S)-3-(BENZYLOXY)-5-(6-(BENZYLOXY)-2-((4-METHOXYPHENYL)DIPHENYLMETHYLAMINO)-9H-PURIN-9-YL)-2-(BENZYLOXYMETHYL)CY...;(Cyclopentanol,5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-,[1S-(1a,2b,3a,5b)]-(9CI) );2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol;Cyclopentanol, 5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, [1S-(1a,2b,3a,5b)]-;Cyclopentanol,5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-,[1S-(1a,2b,3a,5b)]- (9CI);Entecavir Intermediate V;Entecavir N5;(1S,2S,3S,5S)-5-(2-((4-Methoxyphenyl)diphenylMethylaMino)-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)Methyl)cyclopentanol;(1S,3R,4S)-3-(benzyloxy-5;(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9;Entecavir InterMediate ( # );Entecavir-5;(2R,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanol;Entecavir Impurity 1;217B785;(2R,3S,5S)-5-[2-[[(4-Methoxyphenyl)-diphenylmethyl]amino]-6-phenylmethoxypurin-9-yl]-3-phenylmethoxy;Entecavir-5;(1S,2S,3S,5S)-5-[2-[[(4-methoxyphenyl)-diphenylmethyl]amino]-6-phenylmethoxypurin-9-yl]-3-phenylmethoxy-2-(phenylmethoxymethyl)cyclopentan-1-ol;(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopent anol;Entecavir-?5;CID 18651543;J-500990;(1S,2S,3S,5S)-3-(Benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethylamino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanol;C52H49N5O5;Cyclopentanol, 5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)-;142217-78-5;AKOS015998591;SCHEMBL8781302;BS-49394;(1S,2S,3S,5S)-5-[2-[[(4-Methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]cyclopentanol |
| CAS号: | 142217-78-5 |
| 分子式: | C52H49N5O5 |
| 分子量: | 823.98 |
| 密度: | |
| 熔点: | |
| 沸点: | |
| 闪点: | |
| 水溶性: | |
| 蒸气压: |
(1S,2S,3S,5S)-3-(苄氧基)-5-(6-(苄氧基)-2-(((4-甲氧基苯基)二苯甲基)氨基)-9H-嘌呤-9-基)-2-((苄氧基)甲基)环戊醇
英文名:
(1S,2S,3S,5S)-3-(Benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanol
别名:恩替卡韦中间体N5;(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇;(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9;(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基];N,N'-双(1-乙基-3-甲基戊基)-1,4-苯二胺;N,N-双(1-乙基-3-甲基戊基)-1,4-苯二胺;恩替卡韦 中间体-5;恩替卡韦-5;恩替卡韦杂质1;恩替卡韦中间体;恩替卡韦中间体5;恩替卡韦中间体N5,(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇;恩替卡韦中间体五;(2R,3S,5S)-3-苄氧基-5-(2-(((4-甲氧基苯基)二苯基甲基)氨基)-6-苄氧基-9H-嘌呤-9-基)-2-苄氧基甲基环戊醇;(1S,2S,3S,5S)-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-(苯基甲氧基)-9H-嘌呤-9-基]-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇;恩替卡韦中间体 N5
商品编号:R134359-1g
规格:1g
纯度:98%
CAS号: 142217-78-5
分子式:C52H49N5O5
分子量:823.98
| 价格 |
¥ 113.00
(请 登录 会员查看折扣价)
|
| 货期 | 5~7个工作日 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品


















